Zhaoke Ophthalmology Partners with PT Ferron Par Pharmaceuticals to Introduce Atropine Sulphate Eye Drops for Adolescent Myopia Patients in Indonesia

Zhaoke Ophthalmology Obtains China NMPA Medical Device Registration Certificate for TONO-i, its Intraocular Pressure Measurement Device

Zhaoke Ophthalmology Receives Orphan Drug Designation from the U.S FDA for Melphalan Targeting Pediatric Retinoblastoma

Zhaoke Ophthalmology Enhances Global Presence Through Partnership with Top-Tier French Pharmaceutical Company FAREVA

Zhaoke Ophthalmology Announces NMPA Acceptance of New Drug Application for NVK002 (Atropine Sulphate Eye Drops 0.02%) for the Treatment of Myopia Progression in Children